Literature DB >> 10367413

Issues underlying the evaluation of screening programmes.

C S Peckham1, C Dezateux.   

Abstract

Screening programmes have the potential to prevent premature death and disability and to improve quality of life, but they also have the potential for harm. Identifying worthwhile screening programmes, developing the correct strategies, and implementing them effectively is no easy task. A much more critical approach to screening is now being adopted and efforts are being made to ensure that new programmes of proven benefit and which are acceptable to the public, are effectively and equitably implemented in the community. We hope that this issue will stimulate further discussion and debate.

Entities:  

Mesh:

Year:  1998        PMID: 10367413     DOI: 10.1093/oxfordjournals.bmb.a011728

Source DB:  PubMed          Journal:  Br Med Bull        ISSN: 0007-1420            Impact factor:   4.291


  8 in total

Review 1.  Newborn screening for medium chain acyl-CoA dehydrogenase deficiency: evaluating the effects on outcome.

Authors:  Carol Dezateux
Journal:  Eur J Pediatr       Date:  2003-11-20       Impact factor: 3.183

2.  Mortality and recurrence patterns of breast cancer patients diagnosed under a screening programme versus comparable non-screened breast cancer patients from the same population: analytical survey from 2002 to 2012.

Authors:  A García Fernández; C Chabrera; M García Font; M Fraile; J M Lain; S Gónzalez; C Corral; M Torras; J Torres; M Teixido; I Barco; R López; C Gónzalez; A Pessarrodona; N Giménez
Journal:  Tumour Biol       Date:  2013-10-09

Review 3.  Screening for rheumatic heart disease: current approaches and controversies.

Authors:  Kathryn Roberts; Samantha Colquhoun; Andrew Steer; Bo Reményi; Jonathan Carapetis
Journal:  Nat Rev Cardiol       Date:  2012-11-13       Impact factor: 32.419

4.  Cognitive Performance Scores for the Pediatric Automated Neuropsychological Assessment Metrics in Childhood-Onset Systemic Lupus Erythematosus.

Authors:  Patricia Vega-Fernandez; Shana Vanderburgh White; Frank Zelko; Natasha M Ruth; Deborah M Levy; Eyal Muscal; Marisa S Klein-Gitelman; Adam M Huber; Lori B Tucker; Tresa Roebuck-Spencer; Jun Ying; Hermine I Brunner
Journal:  Arthritis Care Res (Hoboken)       Date:  2015-08       Impact factor: 4.794

Review 5.  Pathogenesis and prevention of rheumatic disease: focus on preclinical RA and SLE.

Authors:  Kevin D Deane; Hani El-Gabalawy
Journal:  Nat Rev Rheumatol       Date:  2014-02-11       Impact factor: 20.543

6.  The invisible disease: making sense of an osteoporosis diagnosis in older age.

Authors:  Joanne M Weston; Emma V Norris; Emma M Clark
Journal:  Qual Health Res       Date:  2011-08-02

7.  Screening mammography: what good is it and how can we know if it works?

Authors:  Michael W Vannier
Journal:  J Natl Cancer Inst       Date:  2012-07-17       Impact factor: 13.506

8.  Reference range: Which statistical intervals to use?

Authors:  Wei Liu; Frank Bretz; Mario Cortina-Borja
Journal:  Stat Methods Med Res       Date:  2020-10-14       Impact factor: 3.021

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.